Science Corporation’s brain tech is worth $3.5 billion after new funding
Summary
- Science Corporation, a medical technology start-up founded by Max Hodak in 2021, raised $400 million in a Series D funding round.
- Investors valued the company at $3.5 billion, with backers including Khosla Ventures, the Ackman Oxman Institute, Tenet Healthcare, 885 Capital, Y Combinator, & PLC Neurotech.
- The company's first product is PRIMA, a wearable & implantable chip approved in Europe & available in Germany to help patients with age-related macular degeneration recover vision.
- PRIMA is currently being trialled for patients with Stargardt's disease, a condition that causes blindness.
- Science plans to bring the device to the United States via the FDA's Humanitarian Device Exemption, citing advanced macular degeneration in both eyes as a rare condition.
- The company aims to develop a bio-hybrid sensor combining cultured neurons & silicon to connect directly to the human brain.
- Initial human trials for the bio-hybrid sensor are being designed with Yale neurosurgery professor Murat Günel to potentially treat Parkinson's disease & other brain injuries.
Science Corp raised a $400 million Series D to scale up its anti-blindness business.
- Keywords
- AI,Biotech & Health,Brain,science,Startups